GTS Securities’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-3,400
Closed -$1.77M – 2106
2024
Q3
$1.77M Sell
3,400
-12,200
-78% -$6.52M ﹤0.01% 1653
2024
Q2
$8.45M Buy
15,600
+10,400
+200% +$5.5M 0.02% 570
2024
Q1
$2.7M Sell
5,200
-2,400
-32% -$1.19M ﹤0.01% 1279
2023
Q4
$3.58M Buy
7,600
+2,700
+55% +$1.25M 0.01% 1230
2023
Q3
$2.13M Buy
+4,900
New +$2.22M ﹤0.01% 1469

Other funds holding ELV

GTS Securities's ELV Position: Q3 2026 in Review

GTS Securities increased its Elevance Health (ELV) stake by 233% in Q3 2026, buying an estimated $542K and bringing the position to 1,943 shares worth $755K. The position accounts for 0.02% of the portfolio, ranked #648.

GTS Securities first reported a position in ELV in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.08M in Q4 2023. 1,626 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • GTS Securities held 1,943 shares of Elevance Health worth $755K as of Q3 2026.
  • GTS Securities bought 1,359 Elevance Health shares in Q3 2026, an estimated $542K.
  • Elevance Health made up 0.02% of GTS Securities's portfolio in Q3 2026, its #648 holding.
  • GTS Securities first reported a position in Elevance Health in Q3 2023 and has held it in 12 quarters since.
  • GTS Securities's Elevance Health position peaked at $2.08M in Q4 2023.
  • 1,626 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on GTS Securities's 13F filing for Q3 2026, filed 16 Nov 2026.